Chesley "Sully" Sullenberger III was inducted into the National Aviation Hall of Fame on Thursday in Washington DC, 17 years after he landed US Airways Flight 1549 on the Hudson River with all 155 people aboard surviving. He participated remotely by video. He is 75 years old and living with Alzheimer's disease, which he disclosed publicly in July. The ceremony placed Sullenberger alongside a six-member 2026 class that includes NASA astronauts and aviation researchers. He acknowledged that the 2009 emergency — which became the basis of Clint Eastwood's 2016 film starring Tom Hanks — was central to his enshrinement, but pushed back gently: "My career was much more than one flight." He described a lifetime built around a childhood dream of flying, spent entirely in the Air Force and commercial aviation. The facts of January 15, 2009, remain extraordinary. Flight 1549 departed LaGuardia bound for Charlotte, North Carolina, carrying 150 passengers and five crew. Shortly after takeoff, a bird strike killed both engines. Sullenberger determined the aircraft couldn't make it back to LaGuardia and ditched in the Hudson River. Everyone survived. The event entered the language as the Miracle on the Hudson. What gives this ceremony its second dimension is the Alzheimer's diagnosis. In a Wednesday interview with Good Morning America, Sullenberger described experiencing "all those emotions, the shock, the anger, why me?" His wife Lorrie said on the same program: "This is a disease — not a character flaw. I think we need to talk about it more openly, and maybe other people can do the same." Sullenberger has turned the diagnosis into a platform. "This new phase of my life has challenged what it means to be of service," he said in a statement at the time of disclosure. "And the answer is to speak up." According to the Alzheimer's Association, about 7.4 million Americans aged 65 or older live with clinical Alzheimer's dementia, roughly three out of four of them 75 or older. The two stories — the hall of fame induction and the public reckoning with disease — are doing different kinds of work. The first is institutional recognition for a man whose professional competence saved 155 lives. The second is a deliberate act of vulnerability from someone whose public identity was built on control under pressure. Both are forms of service, and Sullenberger is treating them that way. There is no extraction here, no political angle, no controversy. This is a story about a man being honored for doing his job with extraordinary skill, and choosing to use the spotlight to normalize a disease that 7.4 million Americans share. The ceremony is backward-looking; the advocacy is forward-facing. Sullenberger is doing both at once, which is the most interesting thing about the moment.
